Candan, O.; Tatli, I.; Bakisli, A.; Kula, B.; Korkut, E.; Yildirim, M.E.; Gurbuz, M.A.; Yilmaz, A.F.; Atagunduz, I.; Tuglular, A.T.;
et al. The Impact of Surface CD20 Expression and Soluble CD20 Levels on In Vivo Cell Fragility in Chronic Lymphocytic Leukemia. J. Clin. Med. 2025, 14, 7529.
https://doi.org/10.3390/jcm14217529
AMA Style
Candan O, Tatli I, Bakisli A, Kula B, Korkut E, Yildirim ME, Gurbuz MA, Yilmaz AF, Atagunduz I, Tuglular AT,
et al. The Impact of Surface CD20 Expression and Soluble CD20 Levels on In Vivo Cell Fragility in Chronic Lymphocytic Leukemia. Journal of Clinical Medicine. 2025; 14(21):7529.
https://doi.org/10.3390/jcm14217529
Chicago/Turabian Style
Candan, Ozlem, Imren Tatli, Abdullah Bakisli, Baris Kula, Edanur Korkut, Mehmet Emin Yildirim, Muhammet Ali Gurbuz, Asu Fergun Yilmaz, Isik Atagunduz, Ayse Tulin Tuglular,
and et al. 2025. "The Impact of Surface CD20 Expression and Soluble CD20 Levels on In Vivo Cell Fragility in Chronic Lymphocytic Leukemia" Journal of Clinical Medicine 14, no. 21: 7529.
https://doi.org/10.3390/jcm14217529
APA Style
Candan, O., Tatli, I., Bakisli, A., Kula, B., Korkut, E., Yildirim, M. E., Gurbuz, M. A., Yilmaz, A. F., Atagunduz, I., Tuglular, A. T., & Toptas, T.
(2025). The Impact of Surface CD20 Expression and Soluble CD20 Levels on In Vivo Cell Fragility in Chronic Lymphocytic Leukemia. Journal of Clinical Medicine, 14(21), 7529.
https://doi.org/10.3390/jcm14217529
